Roumier, Christophe <br/><br/>
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).  [electronic resource] 

 -  Blood  Feb 2003 
 - 1277-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2002-05-1474  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bone Marrow--pathology<br/>Core Binding Factor Alpha 2 Subunit<br/>DNA-Binding Proteins--genetics<br/>Gene Rearrangement, T-Lymphocyte<br/>Humans<br/>Immunoglobulin Heavy Chains--genetics<br/>Immunophenotyping<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myeloid, Acute--genetics<br/>Leukocyte Count<br/>Middle Aged<br/>Point Mutation<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Receptors, Antigen, T-Cell--genetics<br/>Retrospective Studies<br/>Survival Rate<br/>Transcription Factors--genetics<br/>fms-Like Tyrosine Kinase 3